Decreased platelet inhibition by P2Y12 receptor blockers in anaemia
- 24 November 2017
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 48 (1) , e12861
Abstract
Background: Anaemic patients undergoing angioplasty and stenting are at an increased risk of ischaemic events, which may be caused by an inadequate response to antiplatelet therapy with adenosine diphosphate (ADP) P2Y12 inhibitors. In the current study, we investigated the associations between anaemia and on‐treatment platelet reactivity in clopidogrel‐treated (group 1, n = 306) and prasugrel‐/ticagrelor‐treated (group 2, n = 109) patients undergoing elective and acute angioplasty with stent implantation, respectively.Materials and methods: Monocyte‐platelet aggregate (MPA) formation was determined by flow cytometry in both groups. On‐treatment residual platelet reactivity in response to ADP was assessed by light transmission aggregometry (LTA) in both groups, and by the VerifyNow P2Y12 assay and the Impact‐R in group 1. P‐selectin expression was measured by flow cytometry in group 2.Results: In both groups, anaemia was associated with significantly higher MPA formation in response to ADP (both P ≤ .02). Moreover, by LTA maximal aggregation in response to ADP was significantly higher in patients with anaemia in both groups (both P < .05), and anaemic patients in group 1 had a significantly higher on‐treatment platelet reactivity by the VerifyNow P2Y12 assay and the Impact‐R than those without anaemia (both P < .001). In group 2, significantly higher platelet surface expression of P‐selectin was seen in anaemia after stimulation with ADP (P = .02).Conclusion: Anaemia is associated with decreased platelet inhibition by ADP P2Y12 receptor antagonists after elective and acute percutaneous interventions with stent implantation. However, due to inconsistencies between different platelet function tests additional data are needed to clarify the role of anaemia for platelet inhibition.Keywords
Funding Information
- Oesterreichische Nationalbank (16155)
This publication has 32 references indexed in Scilit:
- The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependentThrombosis Research, 2011
- A catalogue of reporting guidelines for health researchEuropean Journal of Clinical Investigation, 2009
- Epidemiology of Anemia in Older AdultsSeminars in Hematology, 2008
- Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patientsEuropean Heart Journal, 2008
- Iron and thrombosisAnnals of Hematology, 2007
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Monitoring survival and function of transfused platelets in Bernard‐Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact‐R)Transfusion, 2006
- Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantationEuropean Heart Journal, 2006
- Multiple electrode aggregometry: A new device to measure platelet aggregation in whole bloodThrombosis and Haemostasis, 2006
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003